Product Information
Name:D8-MMAE
Brand:Biosynth
Description:D8-MMAE is a chemical conjugate product, which is composed of the highly potent cytotoxic agent monomethyl auristatin E (MMAE) linked to targeting moieties, often through a stable linker. This product is synthetic in origin, derived from auristatins, which are analogs of dolastatin 10, a natural peptide isolated from marine organisms. The mode of action of D8-MMAE involves specific binding to cellular targets, typically through an antibody-drug conjugate (ADC) mechanism, where the conjugate binds to antigens on cancer cells. Once internalized, the linker is cleaved, releasing MMAE within the cell. MMAE then binds to tubulin, inhibiting cell division by disrupting the microtubule network, leading to apoptosis.
D8-MMAE is utilized primarily in cancer research and development, especially in the creation of ADCs for targeted cancer therapy. Its applications lie in delivering cytotoxic agents directly to cancer cells, thereby minimizing off-target effects and enhancing therapeutic index. This targeted approach is crucial in developing treatments for various malignancies, offering a pathway to more effective and personalized oncology therapies.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:726 g/mol
Formula:C39H67N5O7
Purity:Min. 95%
Technical inquiry about: D8-MMAE
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.